McKinsey Opioids Litigation
McKinsey & Company National Prescription Opiate Consultant Litigation
Lieff Cabraser is court-appointed Lead Counsel in a multidistrict litigation (MDL No. 2996) against management consultant McKinsey & Company, Inc. Filed in 2021, the lawsuit alleges that McKinsey strategized and acted with Purdue Pharma LP and various other opioid manufacturers to create and employ marketing and sales practices to maximize opioid revenues. McKinsey previously agreed to pay $600 million to settle lawsuits by state attorneys general that sought to hold McKinsey accountable for its work with the opioid industry. McKinsey is currently under criminal investigation by the Department of Justice (DOJ) for its opioid work.
Subdivisions and School Districts have settled with McKinsey for $230 million. For more information, see
- Subdivision settlement website: https://www.mckinseysubdivisionclassaction.com
- School Districts settlement website: https://mckinseyschooldistrictopioidsettlement.com
Third-Party Payors have preliminarily settled with McKinsey for $78 million. For more information, see the TPP settlement website: https://www.mckinseytppsettlement.com.
Native American Tribes have settled with McKinsey for $39.5 million. For more information, see the Tribal settlement website: https://www.mckinseytribalsettlement.com.
RESOURCES ON THE OPIOIDS CRISIS AND THE NATIONAL OPIOIDS LITIGATION
List of resources, articles, books, essays, and legal documents relating to the Opioids Crisis and National Multidistrict Prescription Opioids Litigation.
BACKGROUND INFO
Understanding the U.S. Opioid Epidemic
Centers for Disease Control
The Ongoing Opioid Epidemic
The Huffington Post
In-Depth: America’s Opioid Epidemic
CBS News
